ITOC NASDAQ
Credit Risk of going bust: higher than 83% of companies Debt: 1.4% of company value Bonds: none of note held by US funds details ▾
Total debt $244K against a stock market value of $17.3M.
Distance to default 2.33 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $202K (short-term plus half of long-term), stock volatility 148.7%. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Beijing, BE 100101
CN
iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size. Key among its offerings is FTTPS, a sophisticated treatment planning system engineered for diverse malignant tumors. This system excels at defining the target volume, determining the prescribed dose, establishing safety margins for organs at risk, and formulating a precise dose distribution plan essential for brachytherapy patients. Founded in Beijing, China, in 1998, the company operated as Pheton Holdings Ltd. until its rebranding to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. functions as a subsidiary of ZJW (BVI) LTD.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Zhang Jianfei | 0 | — | 2024-09-06 | |
| Zhang Jianfei | 0 | — | 2024-09-06 | |
| Zhang Pengfei | 0 | — | 2024-09-06 | |
| Li Zhixin | 0 | — | 2024-09-06 |